News

• 07.06.05
  ParAllele BioScience And Merck Collaborate To Discover Genetic Variation In Cancer
• 06.13.05
  Affymetrix and ParAllele Launch Industry's Most Comprehensive Product Line for Targeted Genotyping
• 05.31.05
  ParAllele BioScience Signs Agreement to be Acquired by Affymetrix
• 04.27.05
  ParAllele BioScience Collaborates with Both USC and Baylor on Large-Scale Association Studies of Lupus and Respiratory Pathogens
• 04.19.05
  ParAllele Announces Largest Ever Assay Panel Of Non-Synonymous SNPs -Promises a High Pay Off When Used In Disease Association Studies
• 04.06.05
  Genaissance and ParAllele BioScience Sign License and Co-Marketing Agreement
• 03.28.05
  ParAllele BioScience, Inc. and University of Iowa collaborate to discover genes responsible for macular degeneration
• 03.22.05
  ParAllele BioScience, Inc. releases comprehensive non-synonymous SNP panel that can be used in disease association studies
• 03.22.05
  ParAllele Obtains Additional US Patent
• 10.05.04
  ParAllele Enters Collaboration to Study Genetics of Heart Disease
• 07.20.04
  Affymetrix, ParAllele and Cambridge University Collaborate for Large-Scale Genetic Study of Diabetes
• 05.19.04
  ParAllele and Affymetrix Partner to Offer New Custom and Standard GenoTyping Products
• 05.18.04
  ParAllele BioScience and Roche Demonstrate New Approach For Discoverying Disease-Associated Genes
• 05.12.04
  ParAllele Provides National Cancer Institute with Early Access to Megallele" SNP Genotyping Platform
• 05.12.04
  ParAllele BioScience and Merck Collaborate to Discover Genetic Variations in Drug Targets
• 09.23.03
  ParAllele BioScience Secures $22.5 Million in Financing
• 07.29.03
  ParAllele BioScience and Baylor College of Medicine Announce Research Collaboration
• 07.22.03
  ParAllele Names Nick Naclerio President
• 07.09.03
  ParAllele BioScience and Merck to Collaborate on SNP Genotyping Study
• 03.18.03
  Affymetrix to Supply ParAllele BioScience with Genechip® Tag Arrays
• 02.11.03
  ParAllele BioScience Adds André Marion to the Company's Board of Directors
• 10.29.02
  ParAllele BioScience and Baylor Selected by NIH to Build the "Hapmap", a New Public Genome Resource